Abstract Obstructive sleep apnoea (OSA) is a common disorder with numerous potential sequelae. Although the majority ofthese consequences can be reduced with appropriate treatment, onlylimited data exist regarding the natural progression of this disorder in untreated individuals.
INTRODUCTION
Obstructive sleep apnoea (OSA) is a common disorder characterized by the repetitive collapse of the pharyngeal airway during sleep. Its prevalence is 2^4%, and the potentially associated sequelae include reduced quality of life, increased risk of motor vehicle accidents, hypertension, and possibly an increased frequency of myocardial infarction and stroke. While treatment is associated with a reduction in these consequences, the literature regarding the natural progression of the disorder as well as long-term follow-up of therapy is relatively sparse. As treatment of OSA can be poorly tolerated, the risk and bene¢t of no therapy is of clinical importance. The studies that have addressed this issue, were usually either subjective (questionnaire based) or with relatively short-term follow-up. The results of these revealed con£icting conclusions.
In a retrospective study of 118 OSA patients, Lugaresi et al. reported that typical patients had snored for many years prior to development of OSA.They concluded that this is a progressive disease which starts with simple snoring and evolves to full-blown OSA syndrome with increased severity (1) . Likewise, Martikainen et al. found in a population-based questionnaire study that the prevalence of self-reported snoring and pauses between snoring increased in a 5 yr follow-up study (2) . In the few studies performed to evaluate the outcome of untreated OSA patients objectively, two found that mild^moderate OSA may indeed progress over a relatively short period of time (3, 4) , while two others reported that the severity of OSA is stable over time (5, 6) .
In the non-apnoea elderly population the ¢ndings are also inconclusive. Phoda et al. (7) and Bliwise et al. (8) reported mild increases in apnoea indices over time (3 and 5 yrs, respectively) in these populations. In contrast, Ancoli-Israel et al. (9) found no change with high variability of RDI in a triple evaluation study over an 8?5 yrs period.
In a recent study, Lindberg et al. (10) reported a longterm follow-up of 29 men with untreated snoring and daytime somnolence. A repeat PSG 10 years after initial evaluation revealed that 18 had similar RDI between the two studies, while in 11 the RDI increased by more than 5 h
À1
. While in the ¢rst evaluation only one man had an RDI of above 10 h À1 , after 10 yrs eight men fell into this category. This increase in RDI of snorers could not be predicted by any of the baseline measurements (e.g. RDI, BMI, age, or smoking). The group in whom RDI deteriorated did not di¡er from the 'stable' group in worsening of EDS or development of HTN. This study, however, was limited by the population selection of only snorers and not patients with OSA.
As there are only few data in the literature regarding the natural history of apnoea indices in OSA patients, based mainly on relatively short-term follow-up, we planned this study to evaluate changes in apnoea severity and potential sequelae in all untreated patients followedup in our clinic. We hypothesized that patients who choose not to be treated will have relatively mild OSA, and that they would demonstrate deterioration over long-term follow-up both subjectively and objectively. For comparison, we also present data of follow-up of 11 patients who underwent a dietary weight loss program, with somewhat shorter follow-up time.
METHODS Subjects
All untreated patients who were followed-up in our clinic and underwent re-evaluation polysomnography (PSG), were included in the study. In addition, followed-up patients who were in our clinic after participation in a dietary program of weight loss were included as well. These patients who participated in weight reduction programs were instructed to return for a follow-up study once they reached a stable target weight. Patients who underwent a surgical procedure (nasal: septoplasty/turbinectomy, or pharyngeal: LAUP/UPPP) or were on continuous treatment with either continuous positive airway pressure (CPAP) or oral appliance were excluded. All untreated patients in the study were recommended to be treated but chose not to due to either non-compliance with CPAP/dental device or refusal of surgery or both. None of the patients had major otolaryngologic pathology on ENT examination. All the participants were required to evaluate subjectively the spontaneous changes which occurred between the two sleep studies regarding snoring intensity and daytime somnolence. Each patient underwent a medical interview including completing sleep questionnaires, Epworth Sleepiness Scale, brief physical examination including weight and height measurements by the same sleep physician in our lab, and a full night PSG sleep study. Concomitant diseases (speci¢-cally, HTN and IHD) were de¢ned based on diagnosis made by other specialists (PCP, Cardiologist), regardless of this study, and were retrieved from the patients' primary care physician records.
Polysomnography
All patients underwent two full-night PSG studies, with the identical equipment (Nihon Kohden polygraph, EEG-4214, Tokyo, Japan). Recordings consisted of electroencephalography (EEG) (C3-A2), electrooculography (EOG), submental electromyography (EMG), electrocardiography (ECG), £ow (thermistor), respiratory e¡ort (thoracic belt), and leg movements. Data were recorded both on paper (with a paper speed of 1cm sec À1 ), and on computer. Bedtime was between 22:00^23:00 and 06:00 (all patients were awakened at 06:00). In addition, quantitative snoring intensity and arterial oxygen saturation levels were continuously recorded. An oxygen saturation sensor was placed on the ¢fth ¢nger of each subject, and a microphone was placed one meter above the patient's bed.
Scoring and de¢nitions
All scoring was performed based on standard criteria (11) . Apnoea was de¢ned as the complete cessation of air£ow for at least 10 sec. Hypopnoea was de¢ned as any decrement in £ow, if it was associated with either arousal (de¢ned as the appearance of 3 sec of alpha rhythm in the EEG or an increment in submental EMG signal) or oxygen desaturation (of 3% or more). Respiratory Disturbance Index was calculated by dividing the total number of apnoeas + hypopnoeas by total sleep time. The minimal oxygen saturation was determined as the lowest saturation value that was associated with a respiratory event (i.e. excluding artifactually low values due to movements). Likewise, maximal snoring intensity was determined as the maximal decibels recorded by the dB-meter, associated with snoring (i.e. excluding cough or other noises).
Subgroups of patients who 'improved' or 'worsened' were de¢ned as a reduction or increment of 25% or more of the initial RDI, if the change was at least 10 events per h (i.e. to avoid calling a change from an RDI of 10 to 13 'worsening'. In this example 'worsening' would require at least 20 events per h). These arbitrary de¢ni-tions were prespeci¢ed.
Data analysis
All statistical analyses were performed with commercially available software (Excel 97, Microsoft; and SigmaStat, SPSS, Chicago). All data are presented as mean71 SD unless otherwise stated. Two-tailed t-tests for independent samples were used to compare variables between groups or subgroups, and paired t-test to statistically assess the impact of time within patient groups. In each case, Po0?05 was taken to indicate signi¢cance.
RESULTS
Summary data for the untreated and weight loss patients is shown inTable1.The average time interval between the ¢rst and second polysomnographies for the untreated group was 572?8 yrs, and 2?572?3 yrs for the weight reduction group. In the weight-loss group, BMI decreased by a mean of 3?1kgm À2 , and RDI decreased by 20 events h À1 , Po0?05 for both (Table1).There was a signi¢-cant correlation between the weight loss (BMI) and improvement in RDI (R¼0?75, P¼0?005). In the untreated group, there was no signi¢cant change in BMI or RDI (Table 1 ). There was no signi¢cant correlation between changes in weight (BMI) and in RDI in the untreated group. Minimal oxygen saturation in the untreated patients worsened (88710 vs. 85711%, Po0?05), and maximal snoring intensity increased (6078 vs. 6578 dB, Po0?05). Eight untreated patients developed hypertension (n¼5) or ischaemic heart disease (n¼3) over the time course of 5 yrs between the two evaluations ( Table 1) . None of the patients in the weight reduction group developed HTN or IHD during the study period.
The Epworth Sleepiness Scale (ESS) score did not di¡er between the two evaluations (9?274?5 and 9?474?9, respectively). Although 19 patients reported worsening of their complaints, there was no signi¢-cant objective change in their ESS score (8?774?2 and 10?675?0 on the ¢rst and second evaluations, respectively).
The severity of the disorder, patients' BMI or age at the time of the initial evaluation could not predict changes in RDI, snoring intensity or minimal oxygen saturation. Breakdown of the untreated group to three subgroups according to RDI, BMI and age is presented in Table 2 . In none of the subgroups was the change in RDI between the two PSG evaluations signi¢cant. In ¢ve patients the RDI in the second study decreased (improved), while in other six it increased (worsened). Characteristics of these two subgroups are shown inTable 3.The 'improved' group consisted of older patients with worse RDI than the 'worsened' group. Data of the patients who developed hypertension/ischaemic heart disease during the study period are presented in Table 4 . These patients were signi¢cantly older (57 vs. 45 yrs, Po0?05) and had signi¢cantly higher RDI than the other untreated patients (46727 vs. 23717 h À1 , Po0?05). Interestingly, they were also heavier at the time of diagnosis, but they tended to reduce weight compared to the others who tended to gain weight, such that at the time of second evaluation the BMIs of the two groups were similar. There were no di¡erences in other risk factors of HTN/ IHD such as smoking habits (1/8 and 4/32, respectively), hyperlipidaemia (1/8 and 2/32, respectively), diabetes mellitus (1/8 and 2/32, respectively) and alcohol consumption (0/8 and 3/32, respectively) among the patients who developed cardiovascular consequence and those who did not.The subjective evaluation of change in sleepiness/snoring between the two groups was also similar. All the patients presented in this table were untreated.Time between the two evaluations is presented in months.In none of the subgroups (in all categories) was the change in RDI between the two PSG evaluations signi¢cant. The patients who developed HTN/IHD were older, heavier and had more severe OSA at the initial evaluation than those in whom these diseases were not newly diagnosed. However, the diseases were developed despite tendency to reduce BMI in this group as opposed to increased BMI in the other group, such that in the second evaluation the BMIs did not di¡er signi¢cantly between the groups. *Po0?05 between groups.
DISCUSSION
The results of this study suggest that untreated patients with obstructive sleep apnoea syndrome do not necessarily worsen over time, as manifested by similar respiratory disturbance indices. Although relatively long-term follow-up (5 yrs on the average) PSG evaluation of untreated patients revealed in this study somewhat deeper oxygen desaturations and increased intensity of snoring, the clinical relevance of this is unclear. The respiratory disturbance index remained unchanged over 5 yrs of follow-up. None of the tested variables could predict which patients would worsen and which would not.
Trying to conclude regarding the natural history of OSA from a combination of our results with results of previous studies, we believe that OSA is a very gradually progressive disorder. We speculate that it starts with a long period of indolent snoring (1), then progresses to a relatively rapid period of increased frequency of respiratory events (3, 12) , again followed by relatively stable status (5) with potential mild worsening of snoring and oxygen desaturations, as we observed in the present study. In the absence of weight gain, it is impossible at this time to predict which patient will deteriorate and which will not. Both in the present study, and in the previous studies that reported deterioration of apnoea with time, neither age nor BMI correlated with the change in RDI (10) .
The fact that in the two studies reporting deterioration, the RDI was mild-moderate, and in the study that reported stable RDI, it was severe, raises the possibility of a ceiling e¡ect. However, the ¢ndings of this study plus those of Rosenthal et al., that even with low RDIs there is not necessarily progression, somewhat oppose this theory. Likewise, it could be argued that a threshold e¡ect caused increase in RDI in the Svanborg study (12) , however, again, we and others (6, 9) found that even with low RDI there is not necessarily deterioration with time (Table 2) . Furthermore, the very mild change of minimal oxygen saturation recorded in the second evaluation of the untreated group is within the con¢dence limits for this measure, and its clinical relevance is unclear.
Night-to-night variability in RDI can undoubtedly play a role in the ¢ndings of this as well as all the above mentioned papers. It has been previously shown that nightto-night variability in RDI can be as high as 730% (13,14) . Thus, our, and others' (5), attempt to distinguish patients who 'improved' from those who 'worsened' on an individual basis is potentially problematic. For a large group, however, it can be assumed that this random variability will be self-canceling. In addition, it is unlikely that '¢rst-night' e¡ect plays a role given the long time duration between the two studies. Therefore, the group ¢nding of increased ODI from 10?1 to 20?9 over 15?6 months (12), and of RDI from 21?8 to 33?4 over 17 months (3), probably re£ects a real worsening rather than variability. Likewise, the RDI stability we found as well as that reported by others (5) is also probably real and not a result of nightly variability. One possible explanation for the con£icting results is that the patients in the Svandborg and Pendlebury studies (3, 12) were still in the 'rapid deterioration phase' of the disorders, whereas those in Sforza's study and in the current one were beyond that period.We do not know whether the patients in the Sforza study tended to develop hypertension, as this information was not given in that study. In the present study, however, ¢ve out of 34 developed this over a 5-yr period (15%), which is substantially higher than the expected 3^4% incidence of newly diagnosed hypertension in the general population over a similar period (15) . This brings us to the conclusion that even in the absence of RDI deterioration, OSA may continue to progress gradually, with worsening oxygen desaturations and posing a risk for associated diseases such as hypertension (16) . However, the patients who developed new hypertension or ischaemic heart disease were older and heavier than those who did not, which could also contribute to the development of these diseases.
The ¢nding that in the weight-loss group, signi¢cant weight loss was associated with signi¢cant reduction in RDI, is consistent with many previous works (17^22). While these studies have followed up these patients for 0?5^2 yrs, in the present study the follow-up period is 2?572?3 yrs. As previous studies failed to demonstrate correlation between the amount of weight loss and the improvement in apnoea indices (17, 18) , it was unclear whether a critical threshold level for weight loss exists, and which patients were most likely to bene¢t from treatment. The ¢nding in the present study, of a signi¢-cant correlation between the weight loss and improvement in RDI (R¼0?75, P¼0?005), supports the concept that any patient may bene¢t from weight loss, without such a critical threshold.
Our study has several limitations:
(1) Although we chose an unselected group, namely took all patients who were followed-up in our clinic, the group may be biased by the fact that only patients who came to the clinic were analyzed. We cannot predict what would have been the status of untreated patients who had not returned to clinic. One could argue that the most symptomatic would likely return for visits. Alternatively, the most severely a¡ected patients may have been forced into treatment or succumbed to their disease (23, 24) . In order to minimize sampling bias from this population, we chose to study all eligible individuals rather than a speci¢c severity or subgroup.
(2) The number of subjects who participated in this study is too small to draw conclusions regarding the natural history of OSA. However, given that they were followed up both subjectively and objectively for a relatively long period of time, we believe these ¢ndings are important and add to the existing literature. In addition, although only 40 patients participated, these were all eligible individuals, with no patients dropping out due to missing data or technical problems. (3) The follow-up period of the weight loss group is shorter than that of the untreated group. As a result, their OSA severity could have changed over an additional 2?5 yrs of follow up. Previously, we assessed OSA patients, both at short and long periods after weight reduction surgery, and found that they improved in the short-term following surgery, but again worsened in long-term follow-up (25) . Anatomical abnormalities of the upper airway may also be important in predicting the e¡ect of weight loss (26) . However, again, we did not ¢nd gross ENT abnormalities in our patients. (4) Using a patients'/family physician's report as the source of diagnosis of hypertension or ischaemic heart disease may result in underdiagnosis of the problems, since only symptomatic patients were probably diagnosed. Possibly this represents the lower limit of cardiovascular complications in patients with OSA (27) . Including cardiologic evaluation in the protocol may have improved the accuracy of these cardiovascular complications evaluations. However, we believe the new onset diagnosis of these complications could equally be made in all patients and therefore believe the results have not been skewed in any particular direction.
In conclusion, the most striking observations of this study are the relatively stable RDIs in untreated OSA patients over a 5 -yr period. RDI, age and BMI at the time of the initial evaluation were not predictive of changes in RDI, snoring intensity or minimal oxygen saturation, but the patients who developed hypertension/IHD had significantly higher RDI than the patients who did not. Dietary weight reduction is an e¡ective treatment in a 'dose'-related fashion.
